Thoma Bravo to invest in Hypergene to focus on European growth strategy

Hypergene is a Swedish SaaS company for planning and performance management.

  • Hypergene is Thoma Bravo’s third investment by its Europe-based team
  • Monterro and other minority shareholders are the sellers
  • Thoma Bravo is a software investor

Thoma Bravo will acquire a majority stake in Hypergene, a Swedish software-as-a-service (SaaS) company for planning and performance management, from Monterro and other minority shareholders.

Malmö-based Hypergene develops software which is used by the C-Suite and Office of Finance for strategic planning, budgeting and forecasting and project and portfolio management.

Hypergene will focus more on product development and its European growth strategy with this investment, according to a release.

Hypergene is Thoma Bravo’s third investment by its Europe-based team, following its investments in Logex in March 2023 and EQS in November. The firm opened its London office in 2022, which is led by Irina Hemmers.

“Hypergene delivers state of the art analysis and operational capability at a time where flexible planning is more important than ever,” said David Tse, a VP at Thoma Bravo.

This investment is also Thoma Bravo’s second investment in the Nordics following the acquisition of Mercell in 2022.

Hypergene’s CEO Urban Bucht, Jonas Persson, chief financial officer, and founder and chief architect Per Engwall will remain as shareholders and will work closely with Thoma Bravo and the executive Committee.

During Monterro’s holding period, Hypergene increased its annual recurring revenue by over 8x, the release said.

Stockholm-based Monterro is a B2B software investor in the Nordics.

Thoma Bravo is a software investor with around $134 billion in assets as of 30 September. It has offices in Chicago, London, Miami, New York and San Francisco.

Hannes Snellman served as legal counsel to Thoma Bravo.

No financial details of the transaction were disclosed.